This HTML5 document contains 34 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08344/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08344/identifier/pubchem-compound/
n13http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB08344/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08344/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08344
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB08344 n13:DB08344
dcterms:title
4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide
adms:identifier
n8:23644580 n9:99444815 n10:DB08344 n11:P21
n5:IUPAC-Name
n6:271B4EF7-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4EFD-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4EFC-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4EF9-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4EFA-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4EFB-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4EF5-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4EF3-363D-11E5-9242-09173F13E4C5 n6:271B4EF6-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4EF4-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4F03-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4F04-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4EFE-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4EFF-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4F01-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4F00-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4F02-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4F08-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4F0A-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4F0B-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4F07-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4F06-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4F09-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4EF8-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4F05-363D-11E5-9242-09173F13E4C5